Potassium

What it is

Potassium is an essential mineral and electrolyte required for normal cellular function, nerve transmission, and muscle contraction throughout the human body [1]. It is the principal intracellular cation, maintaining fluid and electrolyte balance across cell membranes [2].

Rich dietary sources include potatoes, legumes (lentils, kidney beans), leafy greens (spinach, Swiss chard), squash, avocados, bananas, tomatoes, and salmon [3]. Potassium is also consumed in potassium-enriched salt substitutes, which replace 25% to 30% of standard sodium chloride with potassium chloride [4][5]. Supplement forms include potassium chloride, potassium citrate, potassium bicarbonate, and potassium gluconate [3].

How it might work

Several biological mechanisms explain how potassium influences blood pressure and vascular health [1][2]. First, higher potassium intake promotes natriuresis in the kidneys by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule, which increases urinary sodium excretion and reduces extracellular fluid volume [2][6].

Second, potassium hyperpolarizes vascular smooth muscle cells and stimulates endothelial nitric oxide release, leading to vasodilation and reduced systemic vascular resistance [7][2]. Third, adequate potassium dampens sensitivity to dietary sodium and modulates sympathetic nervous system activity and the renin-angiotensin-aldosterone axis [2][8].

What the research says

Clinical research consistently demonstrates that increasing potassium intake lowers blood pressure, with the most pronounced reductions observed in individuals with elevated baseline blood pressure and high sodium consumption [1][2]. In a 2022 Cochrane systematic review of 20 randomised trials with 21,414 adults, potassium-containing salt substitutes reduced systolic blood pressure by an average of 4.76 mm Hg (95% CI -6.01 to -3.50) and diastolic blood pressure by 2.43 mm Hg (95% CI -3.50 to -1.36) [5]. An updated meta-analysis of 21 trials (31,949 participants) confirmed an overall systolic reduction of 4.61 mm Hg and reported statistically significant reductions in total mortality (risk ratio 0.89, 95% CI 0.85 to 0.94), cardiovascular mortality (risk ratio 0.87, 95% CI 0.81 to 0.94), and cardiovascular events (risk ratio 0.89, 95% CI 0.85 to 0.94) [9].

A landmark World Health Organization systematic review of 22 randomised trials (1,606 participants) found that increased potassium intake reduced systolic blood pressure by 3.49 mm Hg and diastolic by 1.96 mm Hg in adults, with systolic reductions reaching 7.16 mm Hg when higher potassium intake was 90 to 120 mmol per day in people with hypertension [1]. In a systematic review of randomised trials in hypertensive individuals, potassium supplementation decreased systolic blood pressure by 4.48 mm Hg and diastolic by 2.96 mm Hg, with the largest drops observed in participants consuming high sodium diets (4 g or more daily) and those with baseline potassium intake below 90 mmol per day [10].

In the cluster-randomised Salt Substitute and Stroke Study (SSaSS) evaluating 20,995 participants over an average of 4.74 years, using a potassium-enriched salt substitute lowered the rate of stroke by 14% (rate ratio 0.86, 95% CI 0.77 to 0.96) and total mortality by 12% (rate ratio 0.88, 95% CI 0.82 to 0.95) [4]. In a meta-analysis of 16 cohort studies, each 90 mmol per day intake of potassium was associated with a 22% lower risk of incident stroke (relative risk 0.78, 95% CI 0.70 to 0.86) [11]. Modest systolic reductions (around 2.1 to 2.8 mm Hg) have also been recorded in adults with normal baseline blood pressure [12][13].

Doses used in studies

In randomised clinical trials, supplemental potassium doses typically range from 30 to 140 mmol per day (approximately 1,170 to 5,460 mg of potassium per day), commonly administered as potassium chloride [10][2]. Trials evaluating potassium-enriched salt substitutes commonly provide formulations containing 25% to 30% potassium chloride combined with 70% to 75% sodium chloride, replacing discretionary table salt over periods ranging from 2 months to nearly 5 years [4][5].

Public health guidelines, including those from the World Health Organization, recommend a daily dietary potassium intake of at least 90 mmol per day (approximately 3,510 mg per day) from food sources for adults [1]. A dose-response meta-analysis noted that blood pressure reductions leveled off when differences between active and control arms exceeded 30 mmol per day (roughly 1,170 mg per day), suggesting that excessive supplemental intakes offer no additional therapeutic benefit [2].

Safety and interactions

Potassium from food is safe for healthy adults because properly functioning kidneys rapidly excrete excess amounts in urine [1]. However, high-dose oral supplements or concentrated potassium salts can cause adverse gastrointestinal symptoms, including nausea, abdominal pain, diarrhea, and vomiting [3][5].

No official upper intake limit is set for dietary potassium from natural food sources in healthy individuals, but supplemental doses exceeding 3,500 to 4,700 mg per day increase the hazard of hyperkalemia (dangerously high blood potassium) [1][2].

Medication interactions represent a major safety concern. Several widely prescribed classes of drugs reduce the kidneys' ability to eliminate potassium, dramatically increasing the risk of hyperkalemia when combined with potassium supplements or salt substitutes [2][5]. These include angiotensin-converting enzyme (ACE) inhibitors (such as lisinopril and ramipril), angiotensin receptor blockers (ARBs, such as losartan and valsartan), potassium-sparing diuretics (such as spironolactone, eplerenone, amiloride, and triamterene), direct renin inhibitors (aliskiren), and nonsteroidal anti-inflammatory drugs (NSAIDs) [2][5].

Individuals with acute kidney injury, chronic kidney disease (CKD), end-stage renal disease, hypoaldosteronism (such as Addison's disease), or severe liver failure have impaired potassium excretion and must avoid potassium supplements and potassium-enriched salt substitutes unless specifically directed by their physician [14][5]. In a randomised trial in patients with stage 3 CKD, a higher-potassium diet increased blood potassium by 0.21 mmol/L and triggered confirmed hyperkalemia (serum potassium 5.5 mmol/L or higher) in two participants [14]. Severe hyperkalemia is a medical emergency that can cause cardiac conduction abnormalities, dangerous arrhythmias, and cardiac arrest [14][5].

During pregnancy and breastfeeding, obtaining potassium from a balanced, varied diet is safe and vital for maternal and fetal health, but high-dose potassium supplements and potassium-enriched salt substitutes have not been established as safe and should only be taken under direct medical supervision [5].

Caveats and open questions

Several evidence gaps and open questions remain regarding potassium and cardiovascular health [2][5]. First, most clinical trials investigating potassium supplements have been relatively small and of short duration (typically 4 to 12 weeks), limiting evidence on multi-year compliance and long-term hard clinical endpoints [10][2].

Second, large-scale clinical outcome trials on potassium-enriched salt substitutes, including the SSaSS trial, were conducted almost exclusively in rural Chinese villages among older individuals with high stroke risk and high baseline sodium intake; whether identical clinical risk reductions occur in Western populations with lower sodium intake remains an open question [4][9].

Third, in salt substitute trials, reducing sodium occurs simultaneously with increasing potassium, making it difficult to isolate the exact independent magnitude of each mineral's effect, although both changes are physiologically beneficial [6][5]. Finally, head-to-head trials directly comparing whole-food dietary potassium interventions with isolated potassium supplements remain limited [3].